Striverdi
Striverdi is a brand name for olodaterol, a long-acting beta-2 agonist (LABA) inhaled bronchodilator used for maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It is delivered as an inhalation solution via the Respimat SoftMist inhaler and is typically administered once daily.
Olodaterol acts as a selective agonist at beta-2 adrenergic receptors on airway smooth muscle, causing sustained
The medication is administered by inhalation once daily using the Respimat inhaler at the prescribed dose.
Common adverse reactions include upper respiratory tract irritation, cough, and nasopharyngitis; other possible effects include tachycardia
Striverdi was approved for COPD maintenance by major regulatory authorities and has been marketed globally since